Acne removal composition and application and cosmetic thereof
5α reduction is inhibited by the use of white willow bark extract, Magnolia officinalis extract, Centella asiatica extract and complex acne removal extract in the acne removal composition, especially Coptis chinensis, Kawagi and Kidney Tea extracts. Enzyme solves the problems of excessive secretion and inflammation of sebaceous glands in acne, and achieves effective acne removal and skin repair effects.
Patent Information
- Application Number
- CN202410956177.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2044-07-16
AI Technical Summary
The existing technology is difficult to effectively prevent and treat acne, especially how to effectively inhibit the excessive secretion of sebaceous glands and reduce skin inflammation is still an urgent problem.
Provided acne removal composition, including white willow bark extract, Magnolia officinalis extract, Centella asiatica extract and a composite acne removal extract, a composite acne removal extract consisting of Coptis chinensis extract, Kawagioxiang extract and kidney Tea extracts are composed of, formulated through specific mass ratios, inhibit the activity of 5α reductase, reduce skin inflammation and infection, and prevent acne.
This composition can effectively inhibit excessive secretion of sebaceous glands, reduce skin inflammation, repair skin damage, and significantly improve the acne removal effect. At the same time, due to the natural ingredients and small side effects, it reduces infections and complications caused by long-term use of hormones.
Smart Images

Figure CN118873458A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of cosmetic technology, and in particular to an anti-acne composition and its application, and cosmetics. Background Art
[0002] Acne is a chronic inflammatory skin disease of the pilosebaceous gland unit, which is common in adolescence. Its clinical manifestations include facial acne, papules, pustules, nodules and other polymorphic skin lesions. The pathogenesis of acne is as follows: keratinization of hair follicles causes blockage of hair follicles, poor oil discharge, and more and more oil secretion, which accumulates in the hair follicles and sebaceous glands, forming a hotbed for Propionibacterium acnes. When the pores are blocked, they will grow wildly, decompose saturated fatty acids, and produce a large number of free fatty acids. These fatty acids penetrate into the skin through the pores, causing skin stress response, acne, redness and swelling, etc. Bacteria such as Staphylococcus stick to the skin through the pus that flows out, causing damage to the skin tissue and ultimately leading to the growth of a large number of bacteria, while inducing inflammation of the hair follicles and sebaceous glands. In particular, Malassezia can cause keratinocytes to secrete more IL-1β, IL-6, IL-8, TNF-a, and reduce the secretion of IL-10, aggravating the inflammatory response, and further developing into scars, which are somewhat disfiguring. Therefore, how to effectively prevent and treat acne is still a problem that needs to be solved urgently. Summary of the invention
[0003] In view of the problems existing in the prior art, the embodiments of the present application provide an acne-removing composition and its application and cosmetics.
[0004] In a first aspect, the present application provides an anti-acne composition, comprising the following components in parts by weight: 2 parts of white willow bark extract, 0.1 to 10 parts of magnolia bark extract, 0.1 to 5 parts of Centella asiatica extract, and 0.5 to 20 parts of a composite anti-acne extract; wherein:
[0005] The composite anti-acne extract comprises a coptis root extract, a kelp extract and a smilax china extract, wherein the mass ratio of the coptis root extract, the kelp extract and the smilax china extract is 1:(1-4):(1-10).
[0006] In some embodiments, the anti-acne composition comprises the following components in parts by weight: 2 parts of white willow bark extract, 2-4 parts of magnolia bark extract, 2-4 parts of Centella asiatica extract, and 1-10 parts of composite anti-acne extract.
[0007] In some embodiments, in the composite anti-acne extract, the mass ratio of the Coptis chinensis root extract, the Aucklandia lappa extract and the Croton glomerata extract is 1:1:4.
[0008] In a second aspect, the embodiments of the present application provide the use of the anti-acne composition of the embodiments of the first aspect of the present application in cosmetics.
[0009] In some embodiments, based on the total weight of the cosmetic, the weight percentage of the anti-acne composition is 3% to 15%.
[0010] In a third aspect, the embodiments of the present application provide a cosmetic comprising the anti-acne composition of the embodiments of the first aspect of the present application.
[0011] In some embodiments, the cosmetic comprises the following components in percentage by weight: 3% to 15% of the anti-acne composition, 5% to 10% of the auxiliary material, and 75% to 92% of water.
[0012] In some embodiments, the cosmetic comprises the following components in percentage by weight: 5% to 8% of the anti-acne composition, 5% to 10% of auxiliary materials, and 82% to 90% of water.
[0013] In some embodiments, the auxiliary materials include one or more of a humectant, a thickener, a preservative, an emulsifier, a chelating agent, a pH adjuster, and an antioxidant.
[0014] In some embodiments, the humectant includes one or more of glycerin, butylene glycol, glyceryl polyether-26, propylene glycol, hexylene glycol, pentylene glycol, and methylpropanediol.
[0015] In some embodiments, the thickener includes one or more of carbomer, xanthan gum, ammonium acryloyldimethyltaurate / VP copolymer, acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer, and sodium hyaluronate.
[0016] In some embodiments, the preservative includes one or more of phenoxyethanol, chlorphenesin, p-hydroxyacetophenone, glyceryl caprylate, and ethylhexylglycerin.
[0017] In some embodiments, the emulsifier includes one or more of polyglyceryl-6 distearate, glyceryl stearate, cetearyl olivate, sorbitan olivate, lecithin, hydrogenated lecithin, and phosphatidylcholine.
[0018] In some embodiments, the chelating agent includes one or both of disodium ethylenediaminetetraacetic acid and caprylhydroxamic acid.
[0019] In some embodiments, the pH adjuster includes one or more of arginine, sodium hydroxide, potassium hydroxide, triethanolamine, citric acid, and sodium citrate.
[0020] In some embodiments, the antioxidant includes one or more of ascorbic acid, tocopheryl acetate, and sodium metabisulfite. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] In order to more clearly illustrate the technical solution of the embodiments of the present application, the following is a brief introduction to the drawings required for use in the embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without any creative work.
[0022] Figure 1 The figure is a comparison chart of the inhibition rate of 5α-reductase by the samples of Example 1 and Comparative Examples 1 to 3.
[0023] Figure 2 The figure is a comparison chart of the inhibition rate of 5α-reductase by the samples of Examples 1 to 7. DETAILED DESCRIPTION
[0024] The features and exemplary embodiments of various aspects of the present application will be described in detail below. In the detailed description below, many specific details are proposed to provide a comprehensive understanding of the present application. However, it is obvious to those skilled in the art that the present application can be implemented without the need for some of these specific details. The following description of the embodiments is only to provide a better understanding of the present application by illustrating the examples of the present application. In the following description, at least part of the known structures and technologies are not shown to avoid unnecessary ambiguity in the present application; and, for clarity, the size of some structures may be exaggerated. In addition, the features, structures or characteristics described below may be combined in one or more embodiments in any suitable manner.
[0025] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish an entity or operation from another entity or operation, and do not necessarily require or imply that there is any such actual relationship or order between these entities or operations. In the description of the present application, it should be noted that, unless otherwise specified, the meaning of "multiple" is more than two. Moreover, the term "include", "comprise" or any other variant thereof is intended to cover non-exclusive inclusion, so that the process, method, article or equipment including a series of elements not only include those elements, but also include other elements not clearly listed, or also include elements inherent to such process, method, article or equipment. In the absence of more restrictions, the elements limited by the sentence "include..." do not exclude the existence of other identical elements in the process, method, article or equipment including the elements.
[0026] The embodiment of the first aspect of the present application provides an acne-removing composition, comprising the following components in parts by weight: 2 parts of white willow bark extract, 0.1-10 parts of Magnolia officinalis extract, 0.1-5 parts of Centella asiatica extract, and 0.5-20 parts of a composite acne-removing extract; wherein the composite acne-removing extract comprises Coptis chinensis root extract, Aucklandia lappa extract and Camellia oleifera extract, and the mass ratio of Coptis chinensis root extract, Aucklandia lappa extract and Camellia oleifera extract is 1:(1-4):(1-10).
[0027] Coptis chinensis belongs to the Ranunculaceae plant, and its nature and flavor are bitter and cold, and it enters the heart, liver, stomach, and large intestine meridians, and has the effects of clearing away heat and dampness, purging fire and detoxifying. Aucklandia lappa is a plant of the Asteraceae family, and its nature and flavor are bitter and warm, and it enters the liver, spleen, and stomach meridians, and has the effects of aromatic stomachic, promoting qi and relieving pain. Kidney tea belongs to the Labiatae plant, and its taste is sweet, slightly bitter, and its nature is cool, and it belongs to the kidney meridian, and has the effects of clearing away heat and dampness, removing stones and relieving stranguria. The inventor has found through research that after the Coptis chinensis root extract, Sichuan Aucklandia lappa extract and Kidney tea extract are compounded according to a certain ratio, it has a good effect of inhibiting 5α reductase, can effectively inhibit excessive secretion of sebaceous glands, reduce skin inflammation and infection, and then play a role in preventing acne and removing acne. And the above-mentioned composition is all derived from natural plants, has little irritation, and has few side effects, can reduce infections and complications caused by long-term use of hormones, and can play a role in repairing the skin barrier.
[0028] Furthermore, the present application provides an anti-acne composition in which white willow bark extract, magnolia bark extract and centella asiatica extract are added. The white willow bark extract can accelerate the renewal of the stratum corneum and dredge blocked keratin plugs; the magnolia bark extract can play a role in sterilization, anti-inflammatory, and linking skin inflammation; the centella asiatica extract can repair skin damage, fade acne marks, and accelerate wound healing. The combination of white willow bark extract, magnolia bark extract and centella asiatica extract with the composite anti-acne extract can reduce skin inflammation and infection, prevent acne, and repair skin damage well, thereby achieving a good effect of improving skin condition.
[0029] In some embodiments, the anti-acne composition may include the following components in percentage by weight: 2 parts of white willow bark extract, 2-4 parts of magnolia bark extract, 2-4 parts of Centella asiatica extract, and 1-10 parts of composite anti-acne extract. By limiting the content of each component in the anti-acne composition to the above range, it is beneficial to further enhance the anti-acne effect of the anti-acne composition, and at the same time, the combination of each component is more gentle, which can better improve the skin effect.
[0030] In some embodiments, in the composite anti-acne composition, the mass ratio of the coptis root extract, the costus root extract and the nephrolepis chinensis extract is 1:1:4. The inventors have found through experimental research that when the dosage ratio of the coptis root extract, the costus root extract and the nephrolepis chinensis extract is further limited to the above range, it has a better effect of inhibiting 5α-reductase, can enhance the inhibitory effect on excessive secretion of sebaceous glands, further reduce skin inflammation and infection, and enhance the anti-acne effect.
[0031] In some embodiments, the willow bark extract, magnolia bark extract, centella asiatica extract, coptis root extract, costusroot extract and smilax china extract can be extracted by methods commonly used in the art. For example, after the primary extraction is performed by hot solution extraction, the secondary extraction is performed by supercritical extraction.
[0032] Optionally, the solvent for the preliminary extraction may be one or more of water, glycerol, butylene glycol, ethanol, and propylene glycol.
[0033] Optionally, the extraction temperature of the preliminary extraction may be 45°C to 65°C.
[0034] Optionally, the extraction method may include:
[0035] S110, taking the crushed plant material powder and filtering it with a 100-200 mesh filter to remove larger particles;
[0036] S120, mixing the filtered powder with the solvent in a ratio of 1:9, heating to 40°C to 65°C, stirring at a speed of 45 rpm to 60 rpm for 5 h to 10 h, and starting a homogenizer at 3000 rpm to 3500 rpm for 10 min to 20 min during the stirring process;
[0037] S130, after the mixing time is reached, pour the material into the high-pressure microfluidizer, set the pressure to 6000 bar, and pass the high-pressure microfluidizer 5-10 times;
[0038] S140, adding the above preliminarily extracted material into the reactor of the supercritical carbon dioxide extraction equipment for secondary gasification, the specific method is as follows: adding supercritical carbon dioxide, controlling the pressure to 25 MPa to extract the active ingredient, reducing the pressure after the extraction is completed to separate the carbon dioxide, and separating the supernatant;
[0039] S150, the supernatant is purified by passing it through an ion exchange column to obtain an extract.
[0040] The purified extract can be tested for the content of active ingredients in the extract, and after passing the test, it can be disinfected and stored in a sealed container.
[0041] The embodiment of the second aspect of the present application provides the application of the embodiment of the first aspect of the present application in cosmetics.
[0042] The embodiment of the third aspect of the present application provides a cosmetic, including the anti-acne composition of the embodiment of the first aspect of the present application.
[0043] In some embodiments, the cosmetic may include the following components in percentage by weight: 3% to 15% of the anti-acne composition, 5% to 10% of the auxiliary material, and 75% to 92% of water.
[0044] By adding the anti-acne composition of the first embodiment of the present application to cosmetics and limiting the content of its components within the above range, it can play a good role in inhibiting the activity of 5α-reductase, thereby making the cosmetics have good anti-acne effect.
[0045] Optionally, the cosmetic may include the following components in percentage by weight: 5% to 8% of the anti-acne composition, 5% to 10% of the auxiliary material, and 82% to 90% of water. By limiting the content of the anti-acne composition in the cosmetic to the above units, the anti-acne effect of the cosmetic can be further improved.
[0046] In some embodiments, the auxiliary material may include one or more of a humectant, a thickener, a preservative, an emulsifier, a chelating agent, a pH adjuster, and an antioxidant.
[0047] In some embodiments, the humectant may include one or more of glycerin, butylene glycol, glycereth-26, propylene glycol, hexylene glycol, pentylene glycol, and methylpropanediol.
[0048] In some embodiments, the thickener may include one or more of carbomer, xanthan gum, ammonium acryloyldimethyltaurate / VP copolymer, acrylates / C10-30 alkyl acrylate crosspolymer, and sodium hyaluronate.
[0049] In some embodiments, the preservative may include one or more of phenoxyethanol, chlorphenesin, p-hydroxyacetophenone, glyceryl caprylate, and ethylhexylglycerin.
[0050] In some embodiments, the emulsifier may include one or more of polyglyceryl-6 distearate, glyceryl stearate, cetearyl olivate, sorbitan olivate, lecithin, hydrogenated lecithin, and phosphatidylcholine.
[0051] In some embodiments, the chelating agent may include one or both of disodium ethylenediaminetetraacetic acid, caprylhydroxamic acid.
[0052] In some embodiments, the pH adjuster may include one or more of arginine, sodium hydroxide, potassium hydroxide, triethanolamine, citric acid, and sodium citrate.
[0053] In some embodiments, the antioxidant may include one or more of ascorbic acid, tocopheryl acetate, sodium metabisulfite.
[0054] Example
[0055] The present invention is described below with reference to specific examples. It should be noted that the examples described below are exemplary and are only used to explain the present application, and should not be construed as limiting the present application. If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in this area or the product specifications are used. If the manufacturer of the reagents or instruments is not specified, they are all conventional products that can be obtained commercially.
[0056] Example 1
[0057] An acne-removing composition comprises the following components in parts by weight: 2 parts of willow bark extract, 2 parts of magnolia bark extract, 0.2 parts of centella asiatica extract, 1 part of coptis root extract, 1 part of costusroot extract and 4 parts of smilax china extract.
[0058] The auxiliary material is used as phase A, and the above acne-removing composition is used as phase B. The components in phase A are mixed, heated to 80°C, stirred until uniform and free of particles, cooled to 25°C, added to phase B, stirred uniformly, discharged, and the performance test is performed. The ratio of phase A to phase B is shown in Table 1:
[0059] Table 1
[0060]
[0061] Example 2
[0062] The distribution ratio of each group in Example 2 is shown in Table 2.
[0063] Table 2
[0064]
[0065]
[0066] Example 3
[0067] The distribution ratio of each group in Example 3 is shown in Table 3.
[0068] Table 3
[0069]
[0070] Example 4
[0071] The distribution ratio of each group in Example 4 is shown in Table 4.
[0072] Table 4
[0073]
[0074] Example 5
[0075] The distribution ratio of each group in Example 5 is shown in Table 5.
[0076] Table 5
[0077]
[0078] Example 6
[0079] The distribution ratio of each group in Example 6 is detailed in Table 6.
[0080] Table 6
[0081]
[0082] Example 7
[0083] The distribution ratio of each group in Example 7 is shown in Table 7.
[0084] Table 7
[0085]
[0086]
[0087] Comparative Example 1
[0088] The distribution ratios of each group in Comparative Example 1 are shown in Table 8.
[0089] Table 8
[0090]
[0091] Comparative Example 2
[0092] The distribution ratios of each group in Comparative Example 2 are detailed in Table 9.
[0093] Table 9
[0094]
[0095] Comparative Example 3
[0096] The allocation ratios of each group in Comparative Example 3 are detailed in Table 10.
[0097] Table 10
[0098]
[0099] The samples in Examples 1-7 and Comparative Examples 1-3 were mixed with water at a mass ratio of 5:95 to dilute to a concentration of 5%, and then added dropwise to a 5α-reductase source for reaction. The amount added was 0.25wt% of the 5α-reductase source. After complete reaction, the product was separated and then quantitatively analyzed. The analysis results are shown in FIG. Figure 1 and Figure 2 shown.
[0100] Figure 1 The inhibition rates of the samples in Example 1 and Comparative Examples 1-3 on 5α-reductase are shown. It can be seen that the composite anti-acne extract including coptis root extract, costusroot extract and nephrolepis chinensis extract has a significant 5α-reductase inhibitory effect, and the effect is significantly better than the sum of the inhibitory effects of coptis root extract, costusroot extract or nephrolepis chinensis extract on 5α-reductase in the formula alone. It is proved that the composite anti-acne extract including coptis root extract, costusroot extract and nephrolepis chinensis extract in the formula has a synergistic effect on promoting the inhibitory effect of 5α-reductase.
[0101] Figure 2 The inhibition rates of the samples in Examples 1 to 7 on 5α-reductase are shown. By comparing Example 1, Example 2 and Example 3, it is found that as the proportion of kidney tea extract increases, the inhibitory effect of the product on 5α-reductase will gradually increase; by comparing Example 3 and Example 4, when the addition ratio of kidney tea extract increases from 8% to 10%, the inhibitory effect of the product on 5α-reductase is not significantly improved, so kidney tea is at about 8% The optimal ratio; by comparing Example 3, Example 5, Example 6 and Example 7, it can be found that as the addition ratio of Coptis chinensis root extract and Sichuan costus root extract increases, the inhibitory effect of the product on 5α-reductase is enhanced to a certain extent, and the product has the best effect when both are added at 4%.
[0102] Although the present application has been described with reference to preferred embodiments, various modifications may be made thereto and parts thereof may be replaced with equivalents without departing from the scope of the present application. In particular, the various technical features mentioned in the various embodiments may be combined in any manner as long as there are no structural conflicts. The present application is not limited to the specific embodiments disclosed herein, but includes all technical solutions falling within the scope of the claims.
Claims
1. An anti-acne composition, characterized in that: The composition comprises the following components in parts by weight: 2 parts of white willow bark extract, 0.1-10 parts of magnolia bark extract, 0.1-5 parts of Centella asiatica extract, and 0.5-20 parts of compound anti-acne extract; wherein, The composite anti-acne extract comprises a coptis root extract, a kelp extract and a smilax china extract, wherein the mass ratio of the coptis root extract, the kelp extract and the smilax china extract is 1:(1-4):(1-10).
2. The anti-acne composition according to claim 1, characterized in that: The anti-acne composition comprises the following components in parts by weight: 2 parts of white willow bark extract, 2-4 parts of magnolia bark extract, 2-4 parts of Centella asiatica extract, and 1-10 parts of composite anti-acne extract.
3. The anti-acne composition according to claim 1 or 2, characterized in that: In the composite anti-acne extract, the mass ratio of the coptis root extract, the costusroot extract and the smilax china extract is 1:1:
4.
4. Use of the anti-acne composition according to any one of claims 1 to 3 in cosmetics.
5. The use according to claim 4, characterized in that: Based on the total mass of the cosmetic, the weight percentage of the anti-acne composition is 3% to 15%.
6. A cosmetic, characterized in that: The acne-removing composition comprises the anti-acne composition according to any one of claims 1 to 3.
7. The cosmetic according to claim 6, characterized in that: The cosmetic comprises the following components in percentage by weight: 3% to 15% of the anti-acne composition, 5% to 10% of auxiliary materials, and 75% to 92% of water.
8. The cosmetic according to claim 6, characterized in that: The cosmetic comprises the following components in percentage by weight: 5% to 8% of the anti-acne composition, 5% to 10% of auxiliary materials, and 82% to 90% of water.
9. The cosmetic according to claim 7 or 8, characterized in that: The auxiliary materials include one or more of moisturizers, thickeners, preservatives, emulsifiers, chelating agents, pH regulators, and antioxidants.
10. The cosmetic according to claim 9, characterized in that: The moisturizing agent includes one or more of glycerin, butylene glycol, glyceryl polyether-26, propylene glycol, hexylene glycol, pentylene glycol, and methylpropanediol; and / or The thickener includes one or more of carbomer, xanthan gum, ammonium acryloyldimethyltaurate / VP copolymer, acrylic acid (ester) / C10-30 alkyl acrylate cross-linked polymer, and sodium hyaluronate; and / or The preservatives include one or more of phenoxyethanol, chlorphenesin, p-hydroxyacetophenone, glyceryl caprylate, and ethylhexylglycerin; and / or The emulsifier includes one or more of polyglyceryl-6 distearate, glyceryl stearate, cetearyl olive oil ester, sorbitan olive oil ester, lecithin, hydrogenated lecithin, and phosphatidylcholine; and / or The chelating agent includes one or two of disodium ethylenediaminetetraacetic acid and caprylhydroxamic acid; and / or The pH regulator includes one or more of arginine, sodium hydroxide, potassium hydroxide, triethanolamine, citric acid, and sodium citrate; and / or The antioxidant includes one or more of ascorbic acid, tocopherol acetate, and sodium pyrosulfite.
Citation Information
Patent Citations
Acne-removing composition and application thereof
CN111743830A
Anti-inflammatory and acne-removing composition and preparation method thereof
CN113616568A
Acne removing composition with acne mark and acne scar removing effects and preparation method
CN113750015A
Essence capable of cleaning face and removing acnes and preparation method thereof
CN116270367A
Traditional Chinese medicine extract for removing acnes and acne marks as well as preparation method and application of traditional Chinese medicine extract
CN118141722A
